BSE filing, NSE: BALPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Bal Pharma Ltd: key numbers
- Share price
- ₹82.10
- Market cap
- ₹130.7 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 18.1×Sector 47.2×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bal Pharma Ltd
All →Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern as mandated under Regulation 31(1)(b) of the SEBI Listing Regulations.
Bal Pharma Dividend
Bal Pharma disbursed its FY25-26 final dividend of ₹1.20 per share on October 9, 2026. Dividends for shareholders with incomplete KYC or bank details have been withheld.
Bal Pharma Management Change
Bal Pharma Limited announced a change in designations for directors Ravindra Kumar Kothari and Virupakshaya Himesh, effective October 1, 2026.
Bal Pharma Annual General Meeting
Bal Pharma Ltd held its 39th Annual General Meeting on September 24, 2026, where shareholders transacted all business items as per the notice.
Bal Pharma Price Movement Clarification
Bal Pharma has clarified that the recent significant movement in its share price is purely market-driven and not due to any undisclosed price-sensitive information.
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ended March 31, 2026, in compliance with SEBI regulations.
Other board meeting date announcements
All →Lee & Nee Softwares (Exports) Board Meeting Date
Lee & Nee Softwares will hold a board meeting on 13 November 2026 to consider September 2026 quarter and half-year results. The trading window remains closed.
Qualitek Labs Board Meeting Date
Qualitek Labs has given notice of a board meeting on 13 November 2026 to consider half-year unaudited results, an MoA alteration and convening an EGM. The trading window closes from 1 October 2026.
Landmark Property Development Company Board Meeting Date
Landmark Property Development Company has given prior intimation of a board and audit committee meeting on 13 November 2026 to consider unaudited standalone half-yearly results for September 2026. The trading window closes from 1 November 2026.
Meyer Apparel Board Meeting Date
Meyer Apparel intimated a board meeting on 12 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The notice is a future meeting date with no decision yet taken.
Pioneer Embroideries Board Meeting Date
Pioneer Embroideries will meet on 11 November 2026 to consider unaudited standalone and consolidated quarterly and half-year results. Trading window remains closed till 48 hours post-declaration.
Hamps Bio Board Meeting Date
Hamps Bio Limited has given prior intimation of a board meeting on November 6, 2026. The board will consider unaudited standalone and consolidated results for the half year ended September 30, 2026.